Skint Records

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PolarityTE, Hyzon Motors, Nano-X, and Eargo and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, October 28, 2021
Complaint, U.S. Securities and Exchange Commission, Biologics license application, Nano, Insurance, NASDAQ, Microwindows, FDA, EAR, Office of Inspector General, U.S. Department of Health and Human Services, Food, ARC, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, PTE, Skint Records, P.C, Marketing, Company, U.S. Department of Justice Office of Legislative Affairs, Letter, IND, News, Defendant, Control, DOJ, GLOBE, Lists of schools in England, Pharmaceutical industry, Medical device, Audit, Ridesharing company, Risk management

The FDA provided feedback that certain Chemistry, Manufacturing, and Control items need to be addressed prior to proceeding with a pivotal study.

Key Points: 
  • The FDA provided feedback that certain Chemistry, Manufacturing, and Control items need to be addressed prior to proceeding with a pivotal study.
  • The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies.
  • For more information on the Eargo class action go to: https://bespc.com/cases/EAR
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

APPH, PTE & HYZN, HYZNW, DCRC, DCRCW, DCRCU - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Actions and Lead Plaintiff Deadlines

Retrieved on: 
Monday, October 25, 2021
Court, Contract, NASDAQ, FDA, Complaint, Skint Records, LLC, Company, IND, Control, GLOBE, Lists of schools in England, Risk management

You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.

Key Points: 
  • You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.
  • or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at212-697-6484.
  • If you suffered a loss, you can request that the Court appoint you as lead plaintiff.
  • A lead plaintiff acts on behalf of all other class members in directing the litigation.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PolarityTE, Inc. of Class Action Lawsuit and Upcoming Deadline – PTE

Retrieved on: 
Wednesday, October 20, 2021
LLP, Complaint, Court, Pomerantz, Biologics license application, SEC Rule 10b-5, Regenerative medicine, Person, Ext, Patient, NASDAQ, FDA, Food, Medicine, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, PTE, Skint Records, District, Company, Biomedical engineering, Lists of action films, Letter, Skin, IND, News, District court, Control, GLOBE, Burns, Zenith Contract Services, Securities Exchange Act of 1934, Lists of schools in England, Medical device, Pharmaceutical industry

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points: 
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PolarityTE, Hyzon Motors, Nano-X, and Eargo and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, October 20, 2021
IND, EAR, NASDAQ, U.S. Department of Justice Office of Legislative Affairs, News, U.S. Securities and Exchange Commission, Microwindows, DOJ, Lists of schools in England, Complaint, FDA, Control, P.C, Insurance, Defendant, GLOBE, Office of Inspector General, U.S. Department of Health and Human Services, Biologics license application, Letter, Nano, PTE, ARC, Food, Skint Records, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Marketing, Company, Pharmaceutical industry, Medical device, Audit, Ridesharing company, Risk management

The FDA provided feedback that certain Chemistry, Manufacturing, and Control items need to be addressed prior to proceeding with a pivotal study.

Key Points: 
  • The FDA provided feedback that certain Chemistry, Manufacturing, and Control items need to be addressed prior to proceeding with a pivotal study.
  • The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies.
  • For more information on the Eargo class action go to: https://bespc.com/cases/EAR
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PolarityTE, Nano-X, and Eargo and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, October 14, 2021
Lists of schools in England, Nano, U.S. Securities and Exchange Commission, EAR, IND, DOJ, ARC, Complaint, Skint Records, PTE, Insurance, Biologics license application, FDA, U.S. Department of Justice Office of Legislative Affairs, News, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Microwindows, Food, GLOBE, Office of Inspector General, U.S. Department of Health and Human Services, Control, Company, NASDAQ, Letter, P.C, Pharmaceutical industry, Medical device, Audit, Risk management

The FDA provided feedback that certain Chemistry, Manufacturing, and Control items need to be addressed prior to proceeding with a pivotal study.

Key Points: 
  • The FDA provided feedback that certain Chemistry, Manufacturing, and Control items need to be addressed prior to proceeding with a pivotal study.
  • As a result, the study proposed in the IND has been placed on clinical hold.
  • The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies.
  • For more information on the Eargo class action go to: https://bespc.com/cases/EAR
    About Bragar Eagel & Squire, P.C.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PolarityTE, Inc. of Class Action Lawsuit and Upcoming Deadline – PTE

Retrieved on: 
Monday, October 11, 2021
Person, NASDAQ, Company, Control, SEC Rule 10b-5, Ext, Complaint, Food, Letter, District, GLOBE, Burns, District court, Securities Exchange Act of 1934, Biologics license application, LLP, FDA, News, Lists of action films, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Skin, Contract, United, Zenith Contract Services, Skint Records, Biomedical engineering, PTE, Medicine, IND, Patient, Lists of schools in England, Court, Regenerative medicine, Pomerantz, Medical device, Pharmaceutical industry

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points: 
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Koninklije Philips, PayPal, Boston Beer, and PolarityTE and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, October 8, 2021
NASDAQ, Company, Control, SAM, Federal Reserve, Risk, Regulation, Boston Beer Company, Bloomberg L.P. v. Board of Governors of the Federal Reserve System, PHG, Food, Defendant, Letter, Marketing, GLOBE, Growth, Cancer, PayPal, PYPL, SEC, Biologics license application, Form 10-Q, FDA, Structure of the Federal Reserve System, CFPB, News, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, U.S. Securities and Exchange Commission, Disclosure, Skint Records, NYSE, PTE, IND, Boston, CPAP, Lists of schools in England, Board, Medical device, Animal, Risk management, Bank, Pharmaceutical industry

On this news,Philips stock price fell $2.25 per share, or 3.98%, to close at $54.25 per share on June 14, 2021.

Key Points: 
  • On this news,Philips stock price fell $2.25 per share, or 3.98%, to close at $54.25 per share on June 14, 2021.
  • Throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and compliance policies.
  • On this news,PayPals stock price fell $18.81 per share, or 6.23%, to close at $283.17 per share on July 29, 2021.
  • For more information on the PolarityTE class action go to: https://bespc.com/cases/PTE
    About Bragar Eagel & Squire, P.C.

PTE Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies PolarityTE, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, October 7, 2021
Legal, Professional Services, NASDAQ, Company, Control, LLC, Complaint, Securities Exchange Act of 1934, FDA, Review, Skint Records, PTE, IND, Lists of schools in England, Court, Insurance

Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/pte .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/pte .
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
  • If you wish to review a copy of the Complaint you can visit the firms site: www.bgandg.com/pte or you may contact Peretz Bronstein, Esq.
  • or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.

PTE Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies PolarityTE, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, October 5, 2021
Review, NASDAQ, FDA, Complaint, Court, Skint Records, Company, LLC, Control, IND, Advertising, PTE, Securities Exchange Act of 1934, GLOBE, Lists of schools in England, Tobacco

Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/pte .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/pte .
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
  • If you wish to review a copy of the Complaint you can visit the firms site: www.bgandg.com/pte or you may contact Peretz Bronstein, Esq.
  • or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PolarityTE, Inc. of Class Action Lawsuit and Upcoming Deadline – PTE

Retrieved on: 
Monday, October 4, 2021
Biomedical engineering, Food, News, LLP, Biologics license application, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Person, NASDAQ, FDA, Patient, Complaint, Court, Skint Records, SEC Rule 10b-5, Letter, Company, Medicine, District court, Control, Pomerantz, Zenith Contract Services, Ext, IND, Contract, PTE, Burns, Lists of action films, Regenerative medicine, Securities Exchange Act of 1934, District, United, Skin, GLOBE, Lists of schools in England, Private investigator, Medical device, Pharmaceutical industry

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points: 
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members.